Navigation Links
Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
Date:7/28/2008

Regulatory Affairs at Reata Pharmaceuticals. He has held leadership clinical development and medical affairs positions at IDEC Pharmaceuticals Corporation, Biogen Idec and Alpha Therapeutic and also has experience in the medical device arena, previously holding director positions at Abbot Laboratories and Dade Behring. He is Board Certified in Internal Medicine and Hematology. He received his B.S. degree in Chemistry from the University of Michigan, and his M.D. degree and medical training at Duke University.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications. Cardium's lead product candidate, Generx(TM) (alferminogene tadenovec, Ad5FGF4), is a DNA-based growth factor therapeutic being developed for potential use by interventional cardiologists as a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more information about Cardium and its businesses, products and therapeutic candidates, please visit http://www.cardiumthx.com or view its 2007 Annual Report at http://www.cardiumthx.com/flash/pdf/CardiumAR07_Book_FINAL.pdf.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of patient temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 Research ... the "Urinary Slings Market in the US 2015-2019" ... forecast the Urinary Slings market in the US to ... period 2014-2019. This report covers the present scenario ... in the US for the period 2015-2019. To calculate ...
(Date:7/6/2015)... and FARMINGTON, Conn. ... (NYSE MKT: PTN), a biopharmaceutical company developing targeted, ... with significant unmet medical need and commercial potential, ... private placement of Series E warrants to purchase ... F warrants to purchase 2,191,781 shares of its ...
(Date:7/6/2015)... -- Celtaxsys, Inc., a clinical stage pharmaceutical development company ... orphan inflammatory disease indications, announced today that it has ... (FDA) to begin a Phase 2 clinical trial of ... patients in the US. The regulatory submissions to the ... be filed soon after. This groundbreaking clinical study, testing ...
Breaking Medicine Technology:United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... MOUNTAIN VIEW, Calif. , July 29 IRIDEX Corporation (Nasdaq: IRIX ... the market closes on Thursday, August 5, 2010 . ... investment community at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. , ...
... SAVANNAH, Ga. , July 29 MIT Holding, Inc. announces ... of the board of directors. MIT Holding, Inc. founder William "Rocky" Parker ... , , , ... being the senior managing director of Drakeford & Drakeford for the past ...
Cached Medicine Technology:IRIDEX Announces Second Quarter 2010 Conference Call and Release Date 2Walter H.C. Drakeford Named Co-President and Co-Chairman of the Board of Directors for MIT Holding, Inc. 2
(Date:7/4/2015)... New York, NY (PRWEB) , ... July 04, 2015 , ... When a hacker gains ... the home front and at the office. On Wednesday, July 1st, the FTC issued ... their credentials as part of a verification process for a password reset instigated by the ...
(Date:7/3/2015)... ... ... The Harvest Hope Food Bank will hopefully be getting a large donation of ... the area of Greenville SC are making it their mission to collect as many canned ... asking for donations from the public as well. As part of the canned food drive, ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... opened registration for a new SEO training system called "Page One Engine" ... organic traffic generation has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany ...
(Date:7/3/2015)... ... ... Scientists at several top US cancer centers believe they now know why ... here to read the complete story , just posted on the Surviving Mesothelioma website. ... and New York University exposed mice with a mutation on the tumor suppressor gene ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national president recruitment for Regional Care, Inc. in Scottsbluff, Neb. ... Smith has recently placed more than 1,000 healthcare executives into organizations. , ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... be fully solved, but scientists are aware that there is ... brain to mature during //the "critical period" when it is ... Scientists say that the senses of vision, hearing and touch ... system provides an exemplary model for studying developmental plasticity, however, ...
... have banned the import of poultry and livestock from bird ... bothered about the spread of bird flu to domestic or ... that bird flu can be transmitted through animals other than ... from one species to another, it is necessary for both ...
... by a bacterium called Helicobacter pylori and can make the ... //The bacterium is also implicated in gastric cancer and causes ... difficult to treat., ,Many approaches have been taken in ... unsuccessful outcomes. In a recent meta-analysis of therapies published in ...
... confirmed that Germany has donated $870,000 to the U.N. ... at youngsters who are out of school in Myanmar. ... to teach youngsters aged 10 and 17 prevention methods ... other skills. The statement added that the program would ...
... The students are caught between the Karnataka state government and ... that the colleges should abide by all conditions put forth ... private medical colleges have challenged the government. The CET Bill ... It was done to put an end to the controversy ...
... who find themselves in a fix, by not able to find ... as mushrooming coffee bars across the country's metros offers them great ... pressure to find a job in China now have a new ... the country's metros. ,According to a survey by China's ...
Cached Medicine News:Health News:Sensory Input Necessary During "Critical Periods" Of Brain Development 2Health News:Sensory Input Necessary During "Critical Periods" Of Brain Development 3Health News:Animal Facts About Bird Flu Transmission 2Health News:Coffee Bars: A Boon For China's Jobless Youths 2
Halle bone curette, 8 1/4, oval, malleable shaft, 4 mm wide....
Bruns bone curette, 9, oval, solid actagonal handle....
15" overall length, 9" handle....
9.5" overall length, 4.5" handle....
Medicine Products: